Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Serum-Integrated Dopamine-Hyaluronic Acid Hydrogels for Injectable Soft-Tissue Microenvironment Modulation.

Created on 26 Aug 2026

Authors

Vo Minh Quan, Thuy-Kieu Nguyen Thi, Khanh Linh Le, Bao-Han Nguyen-Ngoc, Phuong Le Thi, Khoi Minh Le, My-An Le Tran, Hoan Ngoc Doan, Thi-Hiep Nguyen

Published in

Macromolecular bioscience. Volume 26. Issue 8. Pages e70244.

Abstract

Hyaluronic acid (HA) hydrogels are widely used as injectable fillers for soft-tissue augmentation; however, most currently available formulations primarily provide structural support with limited biological activity. This work establishes design principles for integrating autologous biological components into catechol-based HA (DaHA) hydrogels and underscores the potential of DaHA-serum systems as bioactive injectable platforms. In this study, human whole serum was incorporated into DaHA hydrogels bsy replacing the aqueous phase during hydrogel preparation (0%-10% v/v). Serum incorporation accelerated gelation and altered the viscoelastic behavior of the resulting hydrogels while maintaining injectability through small-gauge needles. Rheological characterization demonstrated stable gel formation, shear recovery, and favorable mechanical properties, whereas moderate serum incorporation (under 10% v/v) preserved swelling behavior and structural stability. Sustained release of serum-derived proteins was observed for at least 8 days, indicating prolonged biochemical availability within the hydrogel matrix. In vitro studies using L929 fibroblasts demonstrated suitable cytocompatibility and enhanced cell survival under serum-free culture conditions. Subcutaneous implantation further confirmed good in vivo tolerance, minimal inflammatory response, and gradual tissue integration. These findings demonstrate that controlled incorporation of human serum provides a practical strategy for engineering bioactive catechol-based hydrogels while preserving the physicochemical properties required for injectable soft-tissue filler applications.

PMID:
42642874
Bibliographic data and abstract were imported from PubMed on 26 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement